True about administration of coicosteroids for fetal lung maturity all of the following except: September 2007
**Core Concept**
The administration of corticosteroids for fetal lung maturity is a crucial aspect of perinatal medicine. It involves the use of corticosteroids, such as betamethasone, to accelerate fetal lung maturation in cases of preterm labor or when preterm delivery is anticipated.
**Why the Correct Answer is Right**
The administration of corticosteroids, specifically betamethasone, stimulates the production of surfactant in the fetal lungs. Surfactant is a critical substance that reduces the surface tension within the alveoli, allowing for easier lung expansion and gas exchange. The administration of betamethasone leads to an increase in the production of surfactant, which improves lung function and reduces the risk of respiratory distress syndrome (RDS) in preterm infants. This is achieved through the stimulation of type II pneumocytes, which produce surfactant.
**Why Each Wrong Option is Incorrect**
**Option A:** This option may be incorrect, but we need the actual options to evaluate it.
**Option B:** This option may be incorrect, but we need the actual options to evaluate it.
**Option C:** This option may be incorrect, but we need the actual options to evaluate it.
**Option D:** This option may be incorrect, but we need the actual options to evaluate it.
**Clinical Pearl / High-Yield Fact**
A commonly used dose of betamethasone for fetal lung maturity is 12 mg intramuscularly every 24 hours for two doses. This dose has been shown to effectively increase surfactant production and reduce the risk of RDS in preterm infants.
**Correct Answer:**
Please provide the actual options for a complete explanation.